Exevin infant nasal drop contains Xylometazoline. It constricts blood vessels in the nasal mucosa, thereby reducing its swelling due to various causes, and makes breathing through the nose easier.
Bottle
₵30.00
EXEVIN INFANT NASAL DROP
Why do you need to give this medicine? Exevin infant nasal drop contains Xylometazoline. It constricts blood vessels in the nasal mucosa, thereby reducing its swelling due to various causes, and makes breathing through the nose easier.
INGREDIENTS
Contains Xylometazoline Hydrochloride (0.05 % w/v)
ADDED INFORMATION
Contains Benzalkonium chloride as preservative. Do not use continuously for more than seven consecutive days. Suitable for infants or children between 2 and 12 years of age. Not recommended for children younger than 2 years.
DOSAGE
Children between 2 and 12 years: 2 to 3 drops of solution in each nostril 2 or 3 times daily
POSSIBLE SIDE EFFECTS
Difficulty breathing or swallowing, swelling of the face, lips, tongue or throat, severe itching of the skin, with a red rash or raised bumps, stinging or burning in the nose and throat, dry nasal mucosa, sneezing, nervousness, headache, dizziness, high BP
WARININGS AND PRECAUTIONS
Direct contact with the eyes be avoided.
Swelling of the nasal mucosa may recur when long-term treatment with xylometazoline is stopped. In order to prevent this treatment period must be kept short as possible.
This medicinal product should not be used by more than one person in order to prevent the risk of spreading infections.
Not recommended to use this medicine, if you are taking medicines that may cause increased blood pressure or taking alpha or beta-blockers.
Should not be used during pregnancy or breast-feeding unless recommended by your doctor.
STORAGE
Keep out of sight and reach of children. Do not use this medicine after the expiry date. After opening, the nasal spray should be used within 6 months. This medicine does not require any special storage conditions.
Do you have any questions? Do not hesitate to contact us.
Reviews
There are no reviews yet.